Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Malerba

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 18, 2022
Systemic Delivery of a Monoclonal Antibody to Immunologically Block Myostatin in the A17 Mouse Model of OPMDAlberto Malerba, Pradeep Harish, Linda Popplewell
Expert Opinion on Biological Therapy|May 22, 2018
The progress of AAV-mediated gene therapy in neuromuscular disordersSara Aguti, Alberto Malerba, Haiyan Zhou
Nucleic Acid Therapeutics|August 20, 2011
Long-term systemic administration of unconjugated morpholino oligomers for therapeutic expression of dystrophin by exon skipping in skeletal muscle: implications for cardiac muscle integrityAlberto Malerba, Luisa Boldrin, George Dickson
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2018
Systemic Intravenous Administration of Antisense Therapeutics for Combinatorial Dystrophin and Myostatin Exon Splice ModulationNgoc Lu-Nguyen, George Dickson, Alberto Malerba
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2025
Systemic Intravenous Administration of Antisense Therapeutics for Combinatorial Dystrophin and Myostatin Exon Splice ModulationNgoc Lu-Nguyen, George Dickson, Alberto Malerba
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2012
Optimizing antisense oligonucleotides using phosphorodiamidate morpholino oligomersLinda J Popplewell, Alberto Malerba, George Dickson
Nucleic Acid Therapeutics|July 31, 2020
Researcher's Perceptions on Publishing "Negative" Results and Open AccessLucía Echevarría, Alberto Malerba, Virginia Arechavala-Gomeza
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2022
Use of Small Animal Models for Duchenne and Parameters to Assess Efficiency upon Antisense TreatmentNgoc Lu-Nguyen, Alberto Malerba, Linda Popplewell
F1000Research|September 6, 2016
Advances in gene therapy for muscular dystrophiesHayder Abdul-Razak, Alberto Malerba, George Dickson
Human Gene Therapy|April 11, 2015
Progress on gene therapy, cell therapy, and pharmacological strategies toward the treatment of oculopharyngeal muscular dystrophyPradeep Harish, Alberto Malerba, George Dickson, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Methods in Molecular Biology (Clifton, N.J.)|November 18, 2022
Systemic Delivery of a Monoclonal Antibody to Immunologically Block Myostatin in the A17 Mouse Model of OPMDAlberto Malerba, Pradeep Harish, Linda Popplewell
Expert Opinion on Biological Therapy|May 22, 2018
The progress of AAV-mediated gene therapy in neuromuscular disordersSara Aguti, Alberto Malerba, Haiyan Zhou
Nucleic Acid Therapeutics|August 20, 2011
Long-term systemic administration of unconjugated morpholino oligomers for therapeutic expression of dystrophin by exon skipping in skeletal muscle: implications for cardiac muscle integrityAlberto Malerba, Luisa Boldrin, George Dickson
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2018
Systemic Intravenous Administration of Antisense Therapeutics for Combinatorial Dystrophin and Myostatin Exon Splice ModulationNgoc Lu-Nguyen, George Dickson, Alberto Malerba
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2025
Systemic Intravenous Administration of Antisense Therapeutics for Combinatorial Dystrophin and Myostatin Exon Splice ModulationNgoc Lu-Nguyen, George Dickson, Alberto Malerba
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2012
Optimizing antisense oligonucleotides using phosphorodiamidate morpholino oligomersLinda J Popplewell, Alberto Malerba, George Dickson
Nucleic Acid Therapeutics|July 31, 2020
Researcher's Perceptions on Publishing "Negative" Results and Open AccessLucía Echevarría, Alberto Malerba, Virginia Arechavala-Gomeza
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2022
Use of Small Animal Models for Duchenne and Parameters to Assess Efficiency upon Antisense TreatmentNgoc Lu-Nguyen, Alberto Malerba, Linda Popplewell
F1000Research|September 6, 2016
Advances in gene therapy for muscular dystrophiesHayder Abdul-Razak, Alberto Malerba, George Dickson
Human Gene Therapy|April 11, 2015
Progress on gene therapy, cell therapy, and pharmacological strategies toward the treatment of oculopharyngeal muscular dystrophyPradeep Harish, Alberto Malerba, George Dickson, et al.
Pageof 6